NeuroMetrix Inc. announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement. Mr. McGillin brings to the company over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.83 USD | +2.13% | +2.68% | +6.39% |
05-15 | NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
+6.39% | 7.45M | |
-6.21% | 180B | |
-0.08% | 109B | |
-3.09% | 68.93B | |
-4.84% | 46.41B | |
+12.85% | 45.43B | |
+7.83% | 43.26B | |
+19.71% | 30.05B | |
+17.94% | 25.19B | |
-7.44% | 23.34B |
- Stock Market
- Equities
- NURO Stock
- News NeuroMetrix, Inc.
- NeuroMetrix Appoints Frank McGillin as Senior Vice President and General Manager, Consumer